A+
|
A
|
A-
|
Skip to main content
|
IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
IPO
Mutual Funds
Commodity
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
IPO
MUTUAL FUND
COMMODITY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Gland Pharma Ltd
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (₹)
656.12
Div & Yield %
0.86
Market Cap (
₹
Cr.)
38,375.07
P/E *
29.13
EPS *
79.97
Face Value (₹)
1
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
2,343.10
Change
-8.20 (-0.35%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
2,308.00 - 2,359.55
52-Week Range
1,511.40 - 2,363.20
Beta (1 Year)
0.72
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Nifty trades below 23,400 level; consumer durables shares tumble
Volumes spurt at J K Cements Ltd counter
Gland Pharma spurts as Q4 PAT jumps 97% YoY to Rs 367 crore
Gland Pharma Ltd leads gainers in 'A' group
Benchmarks end marginally higher; Nifty settles near 23,650 mark
Volumes spurt at Gland Pharma Ltd counter
Gland Pharma to hold AGM
Board of Gland Pharma recommends final dividend
Gland Pharma consolidated net profit rises 96.57% in the March 2026 quarter
Gland Pharma Q4 PAT jumps 97% YoY to Rs 367 crore
Corporate Details
Incorporation Year :
1978
Chairman :
SRINIVAS SADU
Ownership Group :
MNC Associate
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Formulations
Registered Office :
Gland Pharma Ltd
Sy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal,
Hyderabad,
Telangana - 500043,
Phone : 91-40-30510999,
Fax : 91-40-30510800
E-Mail :
investors@glandpharma.com
URL :
http://www.glandpharma.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
15-May-2026
1,867.10
24.75
1Month
22-Apr-2026
1,797.95
29.55
3Month
23-Feb-2026
1,802.40
29.23
6Month
24-Nov-2025
1,791.05
30.05
1Year
22-May-2025
1,544.40
50.82
Mutual Funds Holding
Scheme Name
% Holding
Market Value
HDFC Mid Cap Fund
1.17
1106.12
Mirae Asset Large & Midcap F..
1.37
581.67
SBI Large & Midcap Fund
1.44
555.00
ICICI Pru India Opportunitie..
1.50
542.67
Nippon India Growth Mid Cap ..
1.07
490.22
Peerset : Pharmaceuticals - Indian - Formulations
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Torrent Pharmaceuticals Ltd
4,484.15
0.30
4,555.95
3,103.00
151,764.01
Ajanta Pharma Ltd
3,105.95
-1.34
3,314.80
2,335.00
38,804.38
ERIS Lifesciences Ltd
1,344.35
-2.94
1,909.55
1,237.90
18,628.29
Rubicon Research Ltd
951.20
-1.83
1,019.10
571.00
15,671.05
Caplin Point Laboratories Ltd
2,028.75
0.31
2,396.95
1,502.45
15,420.87
Index Details
BSE 500, BSE HC, BSE Midcap